Trandolapril

This classification denotes an ace inhibitor with the molecular formula C24H34N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1T0N3G9CRC, chemically known as 1h-indole-2-carboxylic acid, octahydro-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, (2s-(1(r*(r*)),2-alpha,3a-alpha,7a-beta))- but generally known as trandolapril, which bears US NIH Compound Identifier 5484727. European Medicines Agency schedules Trandolapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11212MIG. The term TRANDOLAPRIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules trandolapril in its Anatomical Therapeutic Chemical (ATC) Classification. TRANDOLAPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trandolapril under HS 29339990 and SITC 51577. As of Q4 2014, TRANDOLAPRIL remains the US FDA Preferred Term for this commodity. Trandolapril bears US NLM identifiers UMLS ID C0076891 and NCI Concept Code C61978. SMILES: O=C(N1C2C(CC1C(=O)O)CCCC2)C(NC(CCc1ccccc1)C(=O)OCC)C.